Ingo Eitel Author
Subjects of specialization
Affiliation
Imaging Cardiology Cardiovascular System Magnetic Resonance Imaging Myocardial Infarction Atherosclerosis Coronary Artery Disease Magnetic Resonance Acute Myocardial Infarction, cancer oncology, Carcinogenesis
Departments of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lubeck, Lubeck, Germany
Dr. Ingo Eitel is working as scientist and professor at Departments of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lubeck, Lubeck, Germany. The author has specalization in cancer, cancer oncology, chemotherapy, Carcinogenesis, Chemotherapy,Imaging Cardiology Cardiovascular System Magnetic Resonance Imaging Myocardial Infarction Atherosclerosis Coronary Artery Disease Magnetic Resonance Acute Myocardial Infarction
Case Report Subscription
Author(s): Matthias Mezger, Cara Harms, Karolin Schmoll, Aneke Gansewig, Ingo Eitel, Nikolas von Bubnoff and Tobias Graf
Abstract
Over the last years, several new drugs have been launched for the treatment of cancer. Immune checkpoint blockade suppresses intrinsic down-regulators of immunity, such as cytotoxic T-lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death 1 (PD-1) or its ligand, Programmed Cell Death Ligand 1 (PD-L1). Immune checkpoint blockade enhances patient´s immune system and increased survival rates for different cancer subtypes. However, immune checkpoint blockade can lead to autoimmunity with a multitude of side effects that involve the heart, gastrointestinal tract, endocrine glands, skin, CNS and liver. We here present the case of a patient who was admitted to the emergency department with stroke- like symptoms. Whilst monitoring on stroke- unit was o... view moreĀ»